Entertainment news, movies, and celebrities
The FDA's removal of clozapine's monitoring requirements is pivotal, but fear still hinders clinicians from prescribing it to young patients with schizophrenia.
Recent findings confirm that recipients of gene-edited pig kidneys can later receive human organ transplants, marking a significant milestone for xenotransplantation.
Recent drug pricing agreements expand to additional companies, while Novartis and Bristol Myers suspend cell therapy trials due to safety concerns.
Recent research reveals that Paxlovid, a popular Covid-19 treatment, offers no benefit for long Covid patients compared to placebo.
The NIH's recent proposal to limit the number of grants per researcher has sparked varied responses, highlighting ongoing concerns in the biomedical research arena.
MAHA's efforts to reshape American nutrition encounter hurdles stemming from a declining dietitian workforce.
Updated guidelines from leading headache organizations emphasize new migraine treatments while addressing gaps in patient awareness and access.
The Lindsay Clancy case highlights systemic flaws in maternal mental health care, raising concerns about its impact on psychiatrist willingness to treat patients.
AstraZeneca and Ionis' heart disease treatment faced an unexpected failure, raising concerns and interest among biotech competitors like Alnylam.
Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelming scientific refutation.
Cytokinetics is set to submit aficamten for FDA approval, potentially the first drug approved for non-obstructive hypertrophic cardiomyopathy.
AstraZeneca's recent heart disease trial failure underscores the effectiveness of stabilizers over silencers for treating ATTR-CM.
The federal autism advisory committee discusses vaccines as potential autism triggers, sparking controversy amidst calls for more research and transparency.
Roivant's new therapy, Lisraya, recently approved by the FDA, offers a non-steroidal option for treating dermatomyositis.
Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderline risk cases.
The FDA has approved Rasonque, a novel treatment for advanced pancreatic cancer, showing significant improvements in patient outcomes.
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
A new wave of drug trials aims to tackle genetic heart disease risk factors, particularly targeting Lp(a), with major implications for the pharmaceutical market.
Addressing women's health disparities could generate significant economic gains, with estimates suggesting a $1 trillion boost worldwide by 2040.
Recent analyses indicate that post-Dobbs predictions about abortion rates and health impacts may not align with current realities.